3-iodo-alpha-methyltyrosine has been researched along with Skin Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bockslaff, H; Kloster, G | 1 |
| Bubeck, B; Eisenhut, M; Heimke, U; zum Winkel, K | 1 |
2 other study(ies) available for 3-iodo-alpha-methyltyrosine and Skin Neoplasms
| Article | Year |
|---|---|
L-3-123I-alpha-methyltyrosine for melanoma detection: a comparative evaluation.
Topics: Animals; Cell Line; Clioquinol; Cricetinae; Gallium Radioisotopes; Iodine Radioisotopes; Lead; Male; Melanoma; Mesocricetus; Methyltyrosines; Neoplasm Transplantation; Neoplasms, Experimental; Radioisotopes; Radionuclide Imaging; Skin Neoplasms; Tissue Distribution; Tromethamine | 1982 |
Melanoma affine radiopharmaceuticals I. A comparative study of 131I-labeled quinoline and tyrosine derivatives.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoquinolines; Animals; Cricetinae; Eye Neoplasms; Iodine Radioisotopes; Male; Melanoma; Mesocricetus; Methyltyrosines; Neoplasm Transplantation; Neoplasms, Experimental; Radionuclide Imaging; Skin Neoplasms; Tissue Distribution | 1981 |